NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,178 filers reported holding NOVARTIS A G in Q2 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $790,783 | +9.1% | 7,763 | +8.1% | 0.01% | +16.7% |
Q2 2023 | $724,880 | +19.5% | 7,183 | +8.9% | 0.01% | +9.1% |
Q1 2023 | $606,615 | +47.3% | 6,594 | +45.2% | 0.01% | +37.5% |
Q4 2022 | $411,927 | -28.6% | 4,541 | -40.2% | 0.01% | -33.3% |
Q3 2022 | $577,000 | -22.3% | 7,591 | -13.6% | 0.01% | -29.4% |
Q2 2022 | $743,000 | -2.2% | 8,784 | +1.5% | 0.02% | +13.3% |
Q1 2022 | $760,000 | +0.3% | 8,657 | -0.1% | 0.02% | 0.0% |
Q4 2021 | $758,000 | +65.1% | 8,667 | +54.2% | 0.02% | +36.4% |
Q3 2021 | $459,000 | -8.4% | 5,619 | +2.4% | 0.01% | -15.4% |
Q2 2021 | $501,000 | +6.4% | 5,489 | -0.3% | 0.01% | 0.0% |
Q1 2021 | $471,000 | -10.8% | 5,507 | -1.5% | 0.01% | -23.5% |
Q4 2020 | $528,000 | +6.7% | 5,593 | -1.8% | 0.02% | -10.5% |
Q3 2020 | $495,000 | +0.4% | 5,698 | +1.0% | 0.02% | -17.4% |
Q2 2020 | $493,000 | +6.2% | 5,643 | +0.2% | 0.02% | -28.1% |
Q1 2020 | $464,000 | +75.1% | 5,629 | +100.9% | 0.03% | +88.2% |
Q4 2019 | $265,000 | – | 2,802 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
Elefante Mark B | 5,619 | $417,000 | 3.78% |
SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |